Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) has emerged as a sensitive imaging modality for both PCa staging and for highly reproducible intraprostatic tumor delineation [6,7,8,9,10]. This evidence concerns the gene FOLH1 and neoplasm.